Log in

Start free trial
Home 5 Lab Industry Advisor 5 Essential 5 FDA Watch: CDRH Budget May Not See Steep Cuts in FY 2026

FDA Watch: CDRH Budget May Not See Steep Cuts in FY 2026

by | May 22, 2025 | Essential, FDA-lca, FDA-lir, FDA-nir, Industry Buzz-lir, Lab Industry Advisor

A leaked budget document for the next fiscal year suggested non-user fee funding may be up slightly compared to recent years.

The CDRH budget may escape the chopping block in FY 2026.
iStock, new look casting

Sign up for our free weekly Lab & Pathology Insider email newsletter

Subscribe to view Essential

Start a Free Trial for immediate access to this article

TRY FOR FREE